Literature DB >> 29502184

Survival models and health sequences.

Walter Dempsey1, Peter McCullagh2.   

Abstract

Survival studies often generate not only a survival time for each patient but also a sequence of health measurements at annual or semi-annual check-ups while the patient remains alive. Such a sequence of random length accompanied by a survival time is called a survival process. Robust health is ordinarily associated with longer survival, so the two parts of a survival process cannot be assumed independent. This paper is concerned with a general technique-reverse alignment-for constructing statistical models for survival processes, here termed revival models. A revival model is a regression model in the sense that it incorporates covariate and treatment effects into both the distribution of survival times and the joint distribution of health outcomes. The revival model also determines a conditional survival distribution given the observed history, which describes how the subsequent survival distribution is determined by the observed progression of health outcomes.

Entities:  

Keywords:  Interference; Preferential sampling; Quality-of-life; Reverse alignment; Stale values

Mesh:

Substances:

Year:  2018        PMID: 29502184      PMCID: PMC6120816          DOI: 10.1007/s10985-018-9424-9

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  29 in total

1.  Updating of covariates and choice of time origin in survival analysis: problems with vaguely defined disease states.

Authors:  Knut Liestøl; Per Kragh Andersen
Journal:  Stat Med       Date:  2002-12-15       Impact factor: 2.373

2.  Tests and model selection for the general growth curve model.

Authors:  J C Lee
Journal:  Biometrics       Date:  1991-03       Impact factor: 2.571

3.  Joint modelling of repeated measurements and time-to-event outcomes: the fourth Armitage lecture.

Authors:  Peter J Diggle; Inês Sousa; Amanda G Chetwynd
Journal:  Stat Med       Date:  2008-07-20       Impact factor: 2.373

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

6.  BACKWARD ESTIMATION OF STOCHASTIC PROCESSES WITH FAILURE EVENTS AS TIME ORIGINS.

Authors:  Kwun Chuen Gary Chan; Mei-Cheng Wang
Journal:  Ann Appl Stat       Date:  2010-09-01       Impact factor: 2.083

7.  A stochastic model for censored-survival data in the presence of an auxiliary variable.

Authors:  S W Lagakos
Journal:  Biometrics       Date:  1976-09       Impact factor: 2.571

8.  Estimating treatment effects on the marginal recurrent event mean in the presence of a terminating event.

Authors:  Douglas E Schaubel; Min Zhang
Journal:  Lifetime Data Anal       Date:  2010-01-10       Impact factor: 1.588

9.  Semiparametric transformation models with random effects for joint analysis of recurrent and terminal events.

Authors:  Donglin Zeng; D Y Lin
Journal:  Biometrics       Date:  2008-09-29       Impact factor: 2.571

10.  Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.

Authors:  Michael J Crowther; Therese M-L Andersson; Paul C Lambert; Keith R Abrams; Keith Humphreys
Journal:  Stat Med       Date:  2015-10-29       Impact factor: 2.373

View more
  3 in total

1.  Commentary: Alignment of time scales and joint models.

Authors:  Kwun Chuen Gary Chan
Journal:  Lifetime Data Anal       Date:  2018-08-06       Impact factor: 1.588

2.  Risk factors associated with readmissions of patients with severe mental disorders under treatment with antipsychotics.

Authors:  Ronaldo Portela; Milton Leonard Wainberg; Saulo Castel; Helian Nunes de Oliveira; Cristina Mariano Ruas
Journal:  BMC Psychiatry       Date:  2022-03-17       Impact factor: 3.630

3.  Landmarking 2.0: Bridging the gap between joint models and landmarking.

Authors:  Hein Putter; Hans C van Houwelingen
Journal:  Stat Med       Date:  2022-01-31       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.